Australia's most trusted
source of pharma news
Posted 5 August 2022 AM
Newly formed Aussie company Reach Pharmaceuticals is chasing Dr Reddy's Laboratories tail to become the first company to register carboprost - an old medicine used for severe bleeding after childbirth - in Australia.
While Pfizer has marketed the injectable, under the brand name Hemabate, in the US since the 70s, it hasn't registered the drug locally.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.